Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2002 Nov;78(925):641–645. doi: 10.1136/pmj.78.925.641

Magnesium in stroke treatment

K Muir 1
PMCID: PMC1742572  PMID: 12496316

Abstract

Magnesium is involved in multiple physiological processes that may be relevant to cerebral ischaemia, including antagonism of glutamate release, NMDA receptor blockade, calcium channel antagonism, and maintenance of cerebral blood flow. Systemically administered magnesium at doses that double physiological serum concentration significantly reduces infarct volume in animal models of stroke, with a window of up to six hours after onset and favourable dose-response characteristics when compared with previously tested neuroprotective agents. Small clinical trials have reported benefit, but results are not statistically significant in systematic review. A large ongoing trial (IMAGES) will report in 2003–4 and further trials are planned.

Full Text

The Full Text of this article is available as a PDF (149.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisenbrey G. A., Corwin E., Catanzarite V. Effect of magnesium sulfate on the vascular actions of norepinephrine and angiotensin II. Am J Perinatol. 1992 Sep-Nov;9(5-6):477–480. doi: 10.1055/s-2007-999292. [DOI] [PubMed] [Google Scholar]
  2. Andersen M., Overgaard K., Meden P., Boysen G., Choi S. C. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. Stroke. 1999 Jul;30(7):1464–1471. doi: 10.1161/01.str.30.7.1464. [DOI] [PubMed] [Google Scholar]
  3. Astrup J., Siesjö B. K., Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke. 1981 Nov-Dec;12(6):723–725. doi: 10.1161/01.str.12.6.723. [DOI] [PubMed] [Google Scholar]
  4. Bae H., Jeong D., Doh J., Lee K., Yun I., Byun B. Recurrence of bleeding in patients with hypertensive intracerebral hemorrhage. Cerebrovasc Dis. 1999 Mar-Apr;9(2):102–108. doi: 10.1159/000015906. [DOI] [PubMed] [Google Scholar]
  5. Baron J. C. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis. 2001;11 (Suppl 1):2–8. doi: 10.1159/000049119. [DOI] [PubMed] [Google Scholar]
  6. Belfort M. A., Moise K. J., Jr Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol. 1992 Sep;167(3):661–666. doi: 10.1016/s0002-9378(11)91567-1. [DOI] [PubMed] [Google Scholar]
  7. Borges L. F., Gücer G. Effect of magnesium on epileptic foci. Epilepsia. 1978 Feb;19(1):81–91. doi: 10.1111/j.1528-1157.1978.tb05015.x. [DOI] [PubMed] [Google Scholar]
  8. Bradford Andrew, Lees Kennedy. Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial. Curr Control Trials Cardiovasc Med. 2000;1(3):184–190. doi: 10.1186/cvm-1-3-184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brocard J. B., Rajdev S., Reynolds I. J. Glutamate-induced increases in intracellular free Mg2+ in cultured cortical neurons. Neuron. 1993 Oct;11(4):751–757. doi: 10.1016/0896-6273(93)90084-5. [DOI] [PubMed] [Google Scholar]
  10. Chi O. Z., Pollak P., Weiss H. R. Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther. 1990 Mar-Apr;304:196–205. [PubMed] [Google Scholar]
  11. Chien P. F., Khan K. S., Arnott N. Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomised trials. Br J Obstet Gynaecol. 1996 Nov;103(11):1085–1091. doi: 10.1111/j.1471-0528.1996.tb09587.x. [DOI] [PubMed] [Google Scholar]
  12. Cotton D. B., Hallak M., Janusz C., Irtenkauf S. M., Berman R. F. Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures. Am J Obstet Gynecol. 1993 Mar;168(3 Pt 1):974–978. doi: 10.1016/s0002-9378(12)90855-8. [DOI] [PubMed] [Google Scholar]
  13. Davis S. M., Lees K. R., Albers G. W., Diener H. C., Markabi S., Karlsson G., Norris J. Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. Stroke. 2000 Feb;31(2):347–354. doi: 10.1161/01.str.31.2.347. [DOI] [PubMed] [Google Scholar]
  14. Decollogne S., Tomas A., Lecerf C., Adamowicz E., Seman M. NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801. Pharmacol Biochem Behav. 1997 Sep;58(1):261–268. doi: 10.1016/s0091-3057(96)00555-2. [DOI] [PubMed] [Google Scholar]
  15. Di Napoli Mario, Papa Francesca, Villa Pini Stroke Data Bank Investigators Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke. 2002 Jul;33(7):1763–1771. doi: 10.1161/01.str.0000019124.54361.08. [DOI] [PubMed] [Google Scholar]
  16. Ebel H., Günther T. Magnesium metabolism: a review. J Clin Chem Clin Biochem. 1980 May;18(5):257–270. doi: 10.1515/cclm.1980.18.5.257. [DOI] [PubMed] [Google Scholar]
  17. Favaron M., Bernardi P. Tissue-specific modulation of the mitochondrial calcium uniporter by magnesium ions. FEBS Lett. 1985 Apr 22;183(2):260–264. doi: 10.1016/0014-5793(85)80789-4. [DOI] [PubMed] [Google Scholar]
  18. Feldman Z., Gurevitch B., Artru A. A., Oppenheim A., Shohami E., Reichenthal E., Shapira Y. Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. J Neurosurg. 1996 Jul;85(1):131–137. doi: 10.3171/jns.1996.85.1.0131. [DOI] [PubMed] [Google Scholar]
  19. Follis F., Miller K., Scremin O. U., Pett S., Kessler R., Wernly J. NMDA receptor blockade and spinal cord ischemia due to aortic crossclamping in the rat model. Can J Neurol Sci. 1994 Aug;21(3):227–232. doi: 10.1017/s0317167100041202. [DOI] [PubMed] [Google Scholar]
  20. Fuchs-Buder T., Tramèr M. R., Tassonyi E. Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients. J Neurosurg Anesthesiol. 1997 Oct;9(4):324–328. doi: 10.1097/00008506-199710000-00006. [DOI] [PubMed] [Google Scholar]
  21. Gorelick P. B. Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls? Lancet. 2000 Jun 3;355(9219):1925–1926. doi: 10.1016/S0140-6736(00)02318-7. [DOI] [PubMed] [Google Scholar]
  22. Hallak M., Berman R. F., Irtenkauf S. M., Evans M. I., Cotton D. B. Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats. Am J Obstet Gynecol. 1992 Dec;167(6):1605–1610. doi: 10.1016/0002-9378(92)91749-z. [DOI] [PubMed] [Google Scholar]
  23. Hallak M. Effect of parenteral magnesium sulfate administration on excitatory amino acid receptors in the rat brain. Magnes Res. 1998 Jun;11(2):117–131. [PubMed] [Google Scholar]
  24. Harrison N. L., Simmonds M. A. Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985 Feb;84(2):381–391. doi: 10.1111/j.1476-5381.1985.tb12922.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Heath D. L., Vink R. Magnesium sulphate improves neurologic outcome following severe closed head injury in rats. Neurosci Lett. 1997 Jun 13;228(3):175–178. doi: 10.1016/s0304-3940(97)00394-7. [DOI] [PubMed] [Google Scholar]
  26. Helpern J. A., Vande Linde A. M., Welch K. M., Levine S. R., Schultz L. R., Ordidge R. J., Halvorson H. R., Hugg J. W. Acute elevation and recovery of intracellular [Mg2+] following human focal cerebral ischemia. Neurology. 1993 Aug;43(8):1577–1581. doi: 10.1212/wnl.43.8.1577. [DOI] [PubMed] [Google Scholar]
  27. Iseri L. T., French J. H. Magnesium: nature's physiologic calcium blocker. Am Heart J. 1984 Jul;108(1):188–193. doi: 10.1016/0002-8703(84)90572-6. [DOI] [PubMed] [Google Scholar]
  28. Izumi Y., Roussel S., Pinard E., Seylaz J. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab. 1991 Nov;11(6):1025–1030. doi: 10.1038/jcbfm.1991.170. [DOI] [PubMed] [Google Scholar]
  29. Johnson J. W., Ascher P. Voltage-dependent block by intracellular Mg2+ of N-methyl-D-aspartate-activated channels. Biophys J. 1990 May;57(5):1085–1090. doi: 10.1016/S0006-3495(90)82626-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kemp P. A., Gardiner S. M., Bennett T., Rubin P. C. Magnesium sulphate reverses the carotid vasoconstriction caused by endothelin-I, angiotensin II and neuropeptide-Y, but not that caused by NG-nitro-L-arginine methyl ester, in conscious rats. Clin Sci (Lond) 1993 Aug;85(2):175–181. doi: 10.1042/cs0850175. [DOI] [PubMed] [Google Scholar]
  31. Lampl Y., Gilad R., Geva D., Eshel Y., Sadeh M. Intravenous administration of magnesium sulfate in acute stroke: a randomized double-blind study. Clin Neuropharmacol. 2001 Jan-Feb;24(1):11–15. doi: 10.1097/00002826-200101000-00003. [DOI] [PubMed] [Google Scholar]
  32. Lees K. R. Cerestat and other NMDA antagonists in ischemic stroke. Neurology. 1997 Nov;49(5 Suppl 4):S66–S69. doi: 10.1212/wnl.49.5_suppl_4.s66. [DOI] [PubMed] [Google Scholar]
  33. Marinov M. B., Harbaugh K. S., Hoopes P. J., Pikus H. J., Harbaugh R. E. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg. 1996 Jul;85(1):117–124. doi: 10.3171/jns.1996.85.1.0117. [DOI] [PubMed] [Google Scholar]
  34. Mason B. A., Standley C. A., Irtenkauf S. M., Bardicef M., Cotton D. B. Magnesium is more efficacious than phenytoin in reducing N-methyl-D-aspartate seizures in rats. Am J Obstet Gynecol. 1994 Oct;171(4):999–1002. doi: 10.1016/0002-9378(94)90022-1. [DOI] [PubMed] [Google Scholar]
  35. McDonald J. W., Silverstein F. S., Johnston M. V. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett. 1990 Feb 5;109(1-2):234–238. doi: 10.1016/0304-3940(90)90569-u. [DOI] [PubMed] [Google Scholar]
  36. McIntosh T. K., Faden A. I., Yamakami I., Vink R. Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats: 31P magnetic resonance spectroscopy and behavioral studies. J Neurotrauma. 1988;5(1):17–31. doi: 10.1089/neu.1988.5.17. [DOI] [PubMed] [Google Scholar]
  37. McIntosh T. K., Vink R., Yamakami I., Faden A. I. Magnesium protects against neurological deficit after brain injury. Brain Res. 1989 Mar 20;482(2):252–260. doi: 10.1016/0006-8993(89)91188-8. [DOI] [PubMed] [Google Scholar]
  38. Muir K. W., Grosset D. G. Neuroprotection for acute stroke: making clinical trials work. Stroke. 1999 Jan;30(1):180–182. doi: 10.1161/01.str.30.1.180. [DOI] [PubMed] [Google Scholar]
  39. Muir K. W., Lees K. R. Dose optimization of intravenous magnesium sulfate after acute stroke. Stroke. 1998 May;29(5):918–923. doi: 10.1161/01.str.29.5.918. [DOI] [PubMed] [Google Scholar]
  40. Muir K. W. Magnesium for neuroprotection in ischaemic stroke: rationale for use and evidence of effectiveness. CNS Drugs. 2001;15(12):921–930. doi: 10.2165/00023210-200115120-00002. [DOI] [PubMed] [Google Scholar]
  41. Nowak L., Bregestovski P., Ascher P., Herbet A., Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature. 1984 Feb 2;307(5950):462–465. doi: 10.1038/307462a0. [DOI] [PubMed] [Google Scholar]
  42. Okawa M. [Effects of magnesium sulfate on brain damage by complete global brain ischemia]. Masui. 1992 Mar;41(3):341–355. [PubMed] [Google Scholar]
  43. Oppelt W. W., MacIntyre I., Rall D. P. Magnesium exchange between blood and cerebrospinal fluid. Am J Physiol. 1963 Nov;205(5):959–962. doi: 10.1152/ajplegacy.1963.205.5.959. [DOI] [PubMed] [Google Scholar]
  44. Ramsay S. Getting the chemistry right in trials. Lancet. 1998 May 23;351(9115):1528–1528. doi: 10.1016/S0140-6736(05)61118-X. [DOI] [PubMed] [Google Scholar]
  45. Rasmussen H. S., Larsen O. G., Meier K., Larsen J. Hemodynamic effects of intravenously administered magnesium on patients with ischemic heart disease. Clin Cardiol. 1988 Dec;11(12):824–828. doi: 10.1002/clc.4960111205. [DOI] [PubMed] [Google Scholar]
  46. Ravn H. B., Vissinger H., Kristensen S. D., Wennmalm A., Thygesen K., Husted S. E. Magnesium inhibits platelet activity--an infusion study in healthy volunteers. Thromb Haemost. 1996 Jun;75(6):939–944. [PubMed] [Google Scholar]
  47. Reinhart R. A. Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system. Am Heart J. 1991 May;121(5):1513–1521. doi: 10.1016/0002-8703(91)90160-j. [DOI] [PubMed] [Google Scholar]
  48. Samsa G. P., Matchar D. B. Have randomized controlled trials of neuroprotective drugs been underpowered? An illustration of three statistical principles. Stroke. 2001 Mar;32(3):669–674. doi: 10.1161/01.str.32.3.669. [DOI] [PubMed] [Google Scholar]
  49. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Baethmann A., Reulen H. J. Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia. Neurosurgery. 1999 Jan;44(1):163–172. doi: 10.1097/00006123-199901000-00100. [DOI] [PubMed] [Google Scholar]
  50. Sereghy T., Overgaard K., Boysen G. Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats. Stroke. 1993 Nov;24(11):1702–1708. doi: 10.1161/01.str.24.11.1702. [DOI] [PubMed] [Google Scholar]
  51. Shechter M., Hod H., Chouraqui P., Kaplinsky E., Rabinowitz B. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol. 1995 Feb 15;75(5):321–323. doi: 10.1016/s0002-9149(99)80546-3. [DOI] [PubMed] [Google Scholar]
  52. Sibai B. M., Graham J. M., McCubbin J. H. A comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia. Am J Obstet Gynecol. 1984 Nov 15;150(6):728–733. doi: 10.1016/0002-9378(84)90676-8. [DOI] [PubMed] [Google Scholar]
  53. Smith D. A., Connick J. H., Stone T. W. Effect of changing extracellular levels of magnesium on spontaneous activity and glutamate release in the mouse neocortical slice. Br J Pharmacol. 1989 Jun;97(2):475–482. doi: 10.1111/j.1476-5381.1989.tb11975.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Somjen G., Hilmy M., Stephen C. R. Failure to anesthetize human subjects by intravenous administration of magnesium sulfate. J Pharmacol Exp Ther. 1966 Dec;154(3):652–659. [PubMed] [Google Scholar]
  55. Stys P. K., Ransom B. R., Waxman S. G. Effects of polyvalent cations and dihydropyridine calcium channel blockers on recovery of CNS white matter from anoxia. Neurosci Lett. 1990 Jul 31;115(2-3):293–299. doi: 10.1016/0304-3940(90)90471-k. [DOI] [PubMed] [Google Scholar]
  56. Teo K. K., Yusuf S., Collins R., Held P. H., Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ. 1991 Dec 14;303(6816):1499–1503. doi: 10.1136/bmj.303.6816.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Torregrosa G., Perales A. J., Salom J. B., Miranda F. J., Barberá M. D., Alborch E. Different effects of Mg2+ on endothelin-1- and 5-hydroxytryptamine-elicited responses in goat cerebrovascular bed. J Cardiovasc Pharmacol. 1994 Jun;23(6):1004–1010. doi: 10.1097/00005344-199406000-00020. [DOI] [PubMed] [Google Scholar]
  58. Warach S., Pettigrew L. C., Dashe J. F., Pullicino P., Lefkowitz D. M., Sabounjian L., Harnett K., Schwiderski U., Gammans R. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol. 2000 Nov;48(5):713–722. [PubMed] [Google Scholar]
  59. Woods K. L., Fletcher S., Roffe C., Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet. 1992 Jun 27;339(8809):1553–1558. doi: 10.1016/0140-6736(92)91828-v. [DOI] [PubMed] [Google Scholar]
  60. Yang Y., Li Q., Ahmad F., Shuaib A. Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat. Neurosci Lett. 2000 May 12;285(2):119–122. doi: 10.1016/s0304-3940(00)01048-x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES